Cargando…

Epidermal Growth Factor Receptor Inhibition Reduces Angiogenesis via Hypoxia-Inducible Factor-1α and Notch1 in Head Neck Squamous Cell Carcinoma

Angiogenesis, a marker of cancer development, affects response to radiotherapy sensibility. This preclinical study aims to understand the receptor tyrosine kinase-mediated angiogenesis in head neck squamous cell carcinoma (HNSCC). The receptor tyrosine kinase activity in a transgenic mouse model of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wei-Ming, Zhao, Zhi-Li, Ma, Si-Rui, Yu, Guang-Tao, Liu, Bing, Zhang, Lu, Zhang, Wen-Feng, Kulkarni, Ashok B., Sun, Zhi-Jun, Zhao, Yi-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344331/ https://www.ncbi.nlm.nih.gov/pubmed/25723392 http://dx.doi.org/10.1371/journal.pone.0119723

Ejemplares similares

NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell
por: Zhao, Zhi-Li, et al.
Publicado: (2016)

Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma
por: WANG, WEI-MING, et al.
Publicado: (2015)

Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma
por: Sun, Zhi-Jun, et al.
Publicado: (2016)

NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma
por: Shah, Pooja A., et al.
Publicado: (2020)

Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells
por: Dawson, John C., et al.
Publicado: (2011)

Hypoxia-mediated activation of hypoxia-inducible factor-1α in head and neck squamous cell carcinoma: A review
por: Hu, Lanxin, et al.
Publicado: (2023)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

Genome-Wide Enhancer Analysis Reveals the Role of AP-1 Transcription Factor in Head and Neck Squamous Cell Carcinoma
por: Wang, Chen-Yu, et al.
Publicado: (2021)

Transcriptional Activity of Human Epidermal Growth Factor Receptor Family and Angiogenesis Effectors in Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma and Correlation with Patient Outcome
por: Pentheroudakis, George, et al.
Publicado: (2009)

Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines
por: Knuth, Jennifer, et al.
Publicado: (2017)

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
por: Singh, Tripti, et al.
Publicado: (2015)

Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma
por: Porcheri, Cristina, et al.
Publicado: (2019)

An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)

Meta-analysis of the effects of anti-epidermal growth factor receptor on recurrent/metastatic head and neck squamous cell carcinoma
por: Xin, Yong, et al.
Publicado: (2018)

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
por: Yu, Guang-Tao, et al.
Publicado: (2015)

Blockade of adenosine A2A receptor enhances CD8(+) T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
por: Ma, Si-Rui, et al.
Publicado: (2017)

Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development
por: Liu, Yu-Fan, et al.
Publicado: (2016)

Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
por: Stanton, P., et al.
Publicado: (1994)

Exons 19 and 21 of Epidermal Growth Factor Receptor Are Highly Conserved in Squamous Cell Cancer of the Head and Neck
por: Carlson, Matthew, et al.
Publicado: (2009)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck
por: Iberri, David J., et al.
Publicado: (2016)

RhoC Mediates Epidermal Growth Factor-Stimulated Migration and Invasion in Head and Neck Squamous Cell Carcinoma
por: Tumur, Zohra, et al.
Publicado: (2015)

Evaluation of Cyclin D1 and Human Epidermal Growth Factor Receptor 2 Neu Protein Expression in Head and Neck Squamous Cell Carcinoma
por: Sinha, Snigdha, et al.
Publicado: (2023)

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
por: Kim, Jin-Wook
Publicado: (2010)

The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma
por: Zhong, Feng, et al.
Publicado: (2020)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
por: Goel, Arun Kumar, et al.
Publicado: (2009)

Corrigendum: Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development
por: Liu, Yu-Fan, et al.
Publicado: (2016)

Evaluation of the anticancer activity of RIN-1, a Notch signaling modulator, in head and neck squamous cell carcinoma
por: Czerwonka, Arkadiusz, et al.
Publicado: (2023)

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
por: Hofman, P, et al.
Publicado: (2008)

Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
por: Koch, Dominik Thomas, et al.
Publicado: (2017)

Hypoxia Induces Autophagic Cell Death through Hypoxia-Inducible Factor 1α in Microglia
por: Yang, Zhao, et al.
Publicado: (2014)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
por: Hyytiäinen, Aini, et al.
Publicado: (2021)

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
por: Wigfield, S M, et al.
Publicado: (2008)

Cardiac angiogenesis directed by stable Hypoxia Inducible Factor-1
por: Walton, Chad B, et al.
Publicado: (2013)

Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma
por: Liao, Y-H, et al.
Publicado: (2017)

Evaluation of Methylation Profiles of An Epidermal Growth Factor Receptor Gene in a Head and Neck Squamous Cell Carcinoma Patient Group
por: Mutlu, M, et al.
Publicado: (2021)

Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Yang, Zhi-Min, et al.
Publicado: (2022)

TIM-3 and CEACAM1 are Prognostic Factors in Head and Neck Squamous Cell Carcinoma
por: Yang, Fan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ed644sb2re6gflrt7jao8dpi4c